• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状旁腺激素(PTH)在血液透析患者中枢神经系统疾病范围内的意义]

[Significance of parathyroid hormone (PTH) within the scope of central nervous system disorders in hemodialysis patients].

作者信息

Sperschneider H, Stein G, Michael R, Both R, Keil E, Kunath K, Wessel G, Lohr I

出版信息

Z Urol Nephrol. 1987 Apr;80(4):217-27.

PMID:3630425
Abstract

The role of PTH as possible uraemic toxin within the scope of disturbances of the central nervous system (progressive dialysis encephalopathy, PDE) was investigated in 88 patients undergoing haemodialysis. A radioimmunoassay covering the C-terminal PTH fragment was used. Patients undergoing haemodialysis with a PDE showed the highest values with 2,015.4 +/- 457.9 pg/ml, and also in the preclinical stage of a PDE the PTH values with 1,845.7 +/- 663.1 pg/ml lay significantly above those ones of the patients undergoing haemodialysis without PDE (794.8 +/- 364.7 pg/ml). The findings speak for the importance of PTH in the development of complications of the central nervous system within the scope of the uraemia syndrome.

摘要

在88例接受血液透析的患者中,研究了甲状旁腺激素(PTH)作为中枢神经系统紊乱(进行性透析脑病,PDE)范围内可能的尿毒症毒素的作用。使用了一种覆盖C末端PTH片段的放射免疫测定法。患有PDE的血液透析患者的值最高,为2015.4±457.9 pg/ml,并且在PDE的临床前期,PTH值为1845.7±663.1 pg/ml,也显著高于未患PDE的血液透析患者(794.8±364.7 pg/ml)。这些发现表明PTH在尿毒症综合征范围内中枢神经系统并发症的发生中具有重要作用。

相似文献

1
[Significance of parathyroid hormone (PTH) within the scope of central nervous system disorders in hemodialysis patients].[甲状旁腺激素(PTH)在血液透析患者中枢神经系统疾病范围内的意义]
Z Urol Nephrol. 1987 Apr;80(4):217-27.
2
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能及结构的密切关联。
Acta Med Austriaca. 2004 Aug;31(3):67-72.
3
Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.维持性血液透析的终末期肾衰竭患者甲状旁腺激素与左心室功能和结构的密切关联。
J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):3-8.
4
[Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].[血液透析对慢性肾衰竭患者血液中甲状旁腺激素水平的影响]
Wiad Lek. 1993 Apr;46(7-8):283-5.
5
Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
Scand J Urol Nephrol Suppl. 1985;90:51-4.
6
Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?血清甲状旁腺激素水平能否预测血液透析患者的冠状动脉钙化?
Nephrol Dial Transplant. 2007 Nov;22(11):3262-7. doi: 10.1093/ndt/gfm370. Epub 2007 Jun 27.
7
Seasonal changes of parathyroid hormone in chronic hemodialysis patients.
Fukushima J Med Sci. 1993 Jun;39(1):29-33.
8
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
9
PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.甲状旁腺激素与透析患者髋部、脊椎和骨盆骨折风险
Am J Kidney Dis. 2006 Jan;47(1):149-56. doi: 10.1053/j.ajkd.2005.09.024.
10
[Parathyroid hormone values in patients on chronic dialysis treatment].[接受慢性透析治疗患者的甲状旁腺激素值]
Vutr Boles. 1986;25(3):59-62.